Literature DB >> 9537466

Pulmonary adenocarcinomas of the fetal lung type: a clinicopathologic study indicating differences in histology, epidemiology, and natural history of low-grade and high-grade forms.

Y Nakatani1, H Kitamura, Y Inayama, S Kamijo, Y Nagashima, K Shimoyama, N Nakamura, J Sano, N Ogawa, T Shibagaki, M Resl, E J Mark.   

Abstract

Seven cases of high-grade adenocarcinoma of fetal lung type (H-FLAC) are compared with nine cases of pulmonary endodermal tumor resembling fetal lung or low-grade adenocarcinoma of fetal lung type (L-FLAC). Of the seven patients with of H-FLAC, four were men and three were women. All of the patients but one were in their 60s or 70s. Five patients were smokers. After resection of the tumor, three patients died of metastases, two patients are alive with no evidence of disease, and two patients died of a postoperative complication. Histologically, H-FLAC and L-FLAC have both complex glandular structures resembling fetal lung and neuroendocrine differentiation. Two cases of H-FLAC had stromal proliferation typical of biphasic pulmonary blastoma. The H-FLAC was distinguished from L-FLAC by the presence of disorganized glands, large vesicular nuclei, prominent nucleoli, pronounced anisonucleosis, absence of morules, transition to conventional adenocarcinoma, broad areas of necrosis, desmoplastic stroma, overexpression of p53 protein, and production of alpha-fetoprotein. High and low grades of FLAC explain discrepancies in previously reported clinicopathologic features of FLAC. The H-FLAC needs to be distinguished from L-FLAC. Both forms may have stromal components, so both have been referred to as blastomas. The H-FLAC represents the prototype of so-called pulmonary blastoma predominantly seen in the elderly, whereas L-FLAC and its biphasic form predominate in the middle-aged population.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9537466     DOI: 10.1097/00000478-199804000-00003

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  23 in total

1.  Aberration of the Wnt signaling pathway in pulmonary fatal adenocarcinoma: a case report.

Authors:  Junzhe Li; Xinhua Bai; Yufeng Zou; Yanyong Hao; Xianhua Xu
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

2.  Pulmonary well-differentiated fetal adenocarcinoma expressing lineage-specific transcription factors (TTF-1 and GATA-6) to respiratory epithelial differentiation: an immunohistochemical and ultrastructural study.

Authors:  Kazuto Yamazaki
Journal:  Virchows Arch       Date:  2003-04-04       Impact factor: 4.064

3.  Differences between low and high grade fetal adenocarcinoma of the lung: a clinicopathological and molecular study.

Authors:  Jing Zhang; Jian Sun; Xiao-Long Liang; Jun-Liang Lu; Yu-Feng Luo; Zhi-Yong Liang
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

4.  Well-differentiated fetal adenocarcinoma of the lung: clinicopathologic features of 45 cases in China.

Authors:  Tong-Mei Zhang; Bao-Hua Lu; Yi-Ran Cai; Yuan Gao; Hong-Mei Zhang; Qun-Hui Wang; Ai-Min Hu; Bao-Lan Li
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

Review 5.  International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.

Authors:  William D Travis; Elisabeth Brambilla; Masayuki Noguchi; Andrew G Nicholson; Kim R Geisinger; Yasushi Yatabe; David G Beer; Charles A Powell; Gregory J Riely; Paul E Van Schil; Kavita Garg; John H M Austin; Hisao Asamura; Valerie W Rusch; Fred R Hirsch; Giorgio Scagliotti; Tetsuya Mitsudomi; Rudolf M Huber; Yuichi Ishikawa; James Jett; Montserrat Sanchez-Cespedes; Jean-Paul Sculier; Takashi Takahashi; Masahiro Tsuboi; Johan Vansteenkiste; Ignacio Wistuba; Pan-Chyr Yang; Denise Aberle; Christian Brambilla; Douglas Flieder; Wilbur Franklin; Adi Gazdar; Michael Gould; Philip Hasleton; Douglas Henderson; Bruce Johnson; David Johnson; Keith Kerr; Keiko Kuriyama; Jin Soo Lee; Vincent A Miller; Iver Petersen; Victor Roggli; Rafael Rosell; Nagahiro Saijo; Erik Thunnissen; Ming Tsao; David Yankelewitz
Journal:  J Thorac Oncol       Date:  2011-02       Impact factor: 15.609

6.  Well differentiated fetal adenocarcinoma of the lung in a 29 year old woman.

Authors:  K M Sheehan; J Curran; E W Kay; P Broe; A Grace
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

7.  Pulmonary well-differentiated fetal adenocarcinoma with platelet-derived growth factor receptor (PDGFR)α expression.

Authors:  Can-Qiao Luo; Sai-Ching J Yeung; Zhen-Guo Liu; Jun Meng; Fo-tian Zhong; Chao Cheng
Journal:  Cancer Biol Ther       Date:  2012-09-17       Impact factor: 4.742

8.  Transition between morule-like and solid components may occur in solid-predominant adenocarcinoma of the lung: report of 2 cases with EGFR and KRAS mutations.

Authors:  Shogo Tajima; Kenji Koda
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

9.  Well differentiated fetal adenocarcinoma of the lung in a 38-year-old woman: dynamic computed tomography findings.

Authors:  Takana Yamakawa; Atsushi Nambu; Satoshi Kato; Masashi Kawamoto; Shozo Fujino; Masato Watanabe; Masao Tago
Journal:  Jpn J Radiol       Date:  2012-10-31       Impact factor: 2.374

10.  A case of locally advanced well-differentiated fetal adenocarcinoma of the lung treated with concurrent chemoradiation therapy.

Authors:  Chanhee Kyung; Sang Young Kim; Beom Jin Lim; Jung-Joon Cha; Hyung Jung Kim; Chul Min Ahn; Heejin Park; Eun Na Cho; Yoon Soo Chang
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.